Klingenstein Fields & CO LP Bristol Myers Squibb CO Transaction History
Klingenstein Fields & CO LP
- $2.45 Billion
- Q4 2024
A detailed history of Klingenstein Fields & CO LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 8,063 shares of BMY stock, worth $483,941. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,063
Previous 8,582
6.05%
Holding current value
$483,941
Previous $444,000
2.7%
% of portfolio
0.02%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,765Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.52 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.76 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.71 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...